Maury Raycroft
Stock Analyst at Jefferies
(1.69)
# 3,462
Out of 5,135 analysts
59
Total ratings
31.11%
Success rate
-9.85%
Average return
Main Sectors:
Stocks Rated by Maury Raycroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYRA Tyra Biosciences | Maintains: Buy | $32 → $43 | $29.42 | +46.18% | 4 | Feb 3, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Buy | $66 → $81 | $47.47 | +70.63% | 3 | Feb 2, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $114 → $63 | $20.45 | +208.07% | 1 | Dec 30, 2025 | |
| MREO Mereo BioPharma Group | Downgrades: Hold | $7 → $0.5 | $0.42 | +18.76% | 2 | Dec 30, 2025 | |
| CELC Celcuity | Maintains: Buy | $108 → $134 | $105.71 | +26.76% | 2 | Dec 2, 2025 | |
| AUPH Aurinia Pharmaceuticals | Upgrades: Buy | $10 → $21 | $14.31 | +46.75% | 1 | Nov 7, 2025 | |
| OPK OPKO Health | Downgrades: Hold | $2 → $1.6 | $1.22 | +31.15% | 1 | Oct 31, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $550 → $549 | $332.68 | +65.02% | 4 | Oct 30, 2025 | |
| KZR Kezar Life Sciences | Downgrades: Hold | $18 → $7 | $6.53 | +7.20% | 2 | Oct 17, 2025 | |
| KOD Kodiak Sciences | Initiates: Buy | $15 | $24.58 | -38.97% | 1 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $3.5 | $1.56 | +124.36% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $53 | $7.41 | +615.25% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $6.47 | +23.65% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $3 | $0.36 | +727.36% | 1 | Dec 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $12.66 | -52.61% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $12.41 | +53.10% | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $23 → $15 | $3.29 | +355.93% | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.30 | +1,919.52% | 1 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $23 | $1.47 | +1,464.63% | 1 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $195 | $2.37 | +8,127.85% | 1 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $7.26 | +51.52% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $32 → $6 | $44.07 | -86.39% | 2 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $75 | $64.38 | +16.50% | 5 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $3.62 | +204.29% | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $38 → $5 | $1.32 | +278.79% | 2 | Dec 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $10.85 | +231.83% | 1 | Jun 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $105 | $5.92 | +1,673.65% | 1 | May 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $172 | $53.52 | +221.38% | 2 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $2.26 | +1,979.65% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $12.48 | +236.54% | 3 | Nov 1, 2017 |
Tyra Biosciences
Feb 3, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $29.42
Upside: +46.18%
Dianthus Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $66 → $81
Current: $47.47
Upside: +70.63%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Buy
Price Target: $114 → $63
Current: $20.45
Upside: +208.07%
Mereo BioPharma Group
Dec 30, 2025
Downgrades: Hold
Price Target: $7 → $0.5
Current: $0.42
Upside: +18.76%
Celcuity
Dec 2, 2025
Maintains: Buy
Price Target: $108 → $134
Current: $105.71
Upside: +26.76%
Aurinia Pharmaceuticals
Nov 7, 2025
Upgrades: Buy
Price Target: $10 → $21
Current: $14.31
Upside: +46.75%
OPKO Health
Oct 31, 2025
Downgrades: Hold
Price Target: $2 → $1.6
Current: $1.22
Upside: +31.15%
Alnylam Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $550 → $549
Current: $332.68
Upside: +65.02%
Kezar Life Sciences
Oct 17, 2025
Downgrades: Hold
Price Target: $18 → $7
Current: $6.53
Upside: +7.20%
Kodiak Sciences
Sep 22, 2025
Initiates: Buy
Price Target: $15
Current: $24.58
Upside: -38.97%
Jun 24, 2025
Initiates: Hold
Price Target: $3.5
Current: $1.56
Upside: +124.36%
Mar 11, 2025
Maintains: Buy
Price Target: $70 → $53
Current: $7.41
Upside: +615.25%
Feb 10, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $6.47
Upside: +23.65%
Dec 31, 2024
Maintains: Buy
Price Target: $7 → $3
Current: $0.36
Upside: +727.36%
Nov 18, 2024
Initiates: Buy
Price Target: $6
Current: $12.66
Upside: -52.61%
Jul 17, 2024
Initiates: Buy
Price Target: $19
Current: $12.41
Upside: +53.10%
May 7, 2024
Assumes: Buy
Price Target: $23 → $15
Current: $3.29
Upside: +355.93%
Mar 13, 2024
Initiates: Buy
Price Target: $6
Current: $0.30
Upside: +1,919.52%
Mar 5, 2024
Initiates: Buy
Price Target: $23
Current: $1.47
Upside: +1,464.63%
Feb 8, 2024
Initiates: Buy
Price Target: $195
Current: $2.37
Upside: +8,127.85%
Aug 4, 2023
Upgrades: Buy
Price Target: $11
Current: $7.26
Upside: +51.52%
Jan 4, 2023
Downgrades: Hold
Price Target: $32 → $6
Current: $44.07
Upside: -86.39%
Nov 29, 2022
Maintains: Buy
Price Target: $92 → $75
Current: $64.38
Upside: +16.50%
Sep 12, 2022
Initiates: Buy
Price Target: $11
Current: $3.62
Upside: +204.29%
Dec 2, 2021
Downgrades: Hold
Price Target: $38 → $5
Current: $1.32
Upside: +278.79%
Jun 1, 2021
Initiates: Buy
Price Target: $36
Current: $10.85
Upside: +231.83%
May 27, 2021
Initiates: Buy
Price Target: $105
Current: $5.92
Upside: +1,673.65%
Apr 21, 2021
Upgrades: Buy
Price Target: $172
Current: $53.52
Upside: +221.38%
Feb 24, 2020
Initiates: Buy
Price Target: $47
Current: $2.26
Upside: +1,979.65%
Nov 1, 2017
Maintains: Buy
Price Target: $36 → $42
Current: $12.48
Upside: +236.54%